Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online August 23, 2024.
Article Versions
- previous version (September 15, 2023 - 07:31).
- You are viewing the most recent version of this article.
Copyright & Usage
© PDA, Inc. 2024
Author Information
- Patricia Parris1,*,
- Geraldine Whelan2,
- Anders Burild3,
- Jessica Whritenour4,
- Uma Bruen5,
- Joel Bercu6,
- Courtney Callis7,
- Martyn L. Chilton8,
- Jessica Graham9,
- Esther Johann10,
- Candice Johnson11,
- Troy Griffin12,
- Martin Kohan13,
- Elizabeth A. Martin14,
- Melisa Masuda-Herrera6,
- Brad Stanard15,
- Maureen T. Cruz1,7 and
- Lee Nagao16
- 1Pfizer Worldwide Research, Development and Medical, Sandwich, United Kingdom;
- 2GlaxoSmithKline, Ware, United Kingdom;
- 3Novo Nordisk A/S, Safety Sciences and Imaging, Måløv, Denmark;
- 4Pfizer Worldwide Research, Development and Medical, Groton, CT;
- 5Organon USA Inc., Jersey City, NJ;
- 6Gilead Sciences Inc., Foster City, CA;
- 7Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, IN;
- 8Lhasa Limited, Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, United Kingdom;
- 9Genentech, Inc., South San Francisco, CA;
- 10Merck KGaA, Darmstadt, Germany;
- 11Instem, 1393 Dublin Road, Columbus, OH ;
- 12Teva Branded Pharmaceutical Products R&D, West Chester, PA;
- 13formerly of Global Sustainability, AstraZeneca, Cambridge, United Kingdom;
- 14Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom; and
- 15Ultragenyx Pharmaceutical Inc., Novato, CA
- 16Faegre Drinker Biddle & Reath LLP, Washington, DC
- ↵* Corresponding Author: Drug Safety Research & Development, Portfolio, Regulatory Strategy, Pfizer Worldwide Research, Sandwich, Kent, United Kingdom CT13 9NJ; Telephone: +44 7880414083; E-mail: Patricia.parris@pfizer.com
Cited By...
In This Issue
Jump to section
- Article
- Abstract
- Introduction
- Methods
- Results
- Discussion
- Future Work
- Conclusion
- Acknowledgements
- Appendix 1. Information Sources for Literature Search and ELSIE Safety Database
- Appendix 2. Raw Data and In Silico Assessment of Sensitizers with and without an EC3 Potency Value
- Appendix 3. Local Effects Monographs of 15 Chemicals Predicted Strong or Extreme Skin Sensitizers
- A4. Additional Monographs for 1 Extreme Skin Sensitizer and 1 Predicted Strong Skin Sensitizer Added Following Creation of the Potency Dataset
- References
- Figures & Data
- References
- Info & Metrics